Anti-SKP2 antibody
0
(1 Review)
|
(22 Publications)
Rabbit Polyclonal SKP2 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 22 publications. Immunogen corresponding to Synthetic Peptide within Human SKP2 aa 1-50.
View Alternative Names
FBXL1, SKP2, S-phase kinase-associated protein 2, Cyclin-A/CDK2-associated protein p45, F-box protein Skp2, F-box/LRR-repeat protein 1, p45skp2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SKP2 antibody (AB68455)
Immunofluorescence analysis of SKP2 using Anti-SKP2 antibody. SKP2 was detected in a immunocytochemical section of SiHa cell. Enzyme antigen retrieval was performed using IHC enzyme antigen retrieval reagent for 15 minutes. The cells were blocked with 10% goat serum. The cells were then incubated with 5 μg/mL ab68455 and Mouse anti-Tubulin Alpha antibody overnight at 4°C. DyLight®488 Conjugated Goat Anti-Rabbit IgG and Cy3 Conjugated Goat Anti-Mouse IgG were used as secondary antibodies at 1 : 500 dilution and incubated for 30 minutes at 37°C. Visualized using a fluorescence microscope and filter sets appropriate for the label used.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-SKP2 antibody (AB68455)
Flow cytometric analysis of 4% paraformaldehyde fixed and permeabilized HepG2 cells. The cells were blocked with 10% normal goat serum, then incubated with ab68455 (1 μg/1x106 cells) for 30 min at 20°C. DyLight®488 conjugated goat anti-rabbit IgG (5-10 μg/1x106 cells) was used as secondary antibody for 30 minutes at 20°C. Isotype control antibody (Green line) was Rabbit IgG (1 μg/1x106) used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
- WB
Supplier Data
Western blot - Anti-SKP2 antibody (AB68455)
Blocking buffer : 5% non-fat milk/TBS
All lanes:
Western blot - Anti-SKP2 antibody (ab68455) at 0.5 µg/mL
Lane 1:
Human 293T whole cell lysates at 30 µg
Lane 2:
Human Jurkat whole cell lysates at 30 µg
Lane 3:
Human HepG2 whole cell lysates at 30 µg
Lane 4:
Human MCF-7 whole cell lysates at 30 µg
Secondary
All lanes:
Goat anti-rabbit IgG-HRP secondary antibody at 1/5000 dilution
Observed band size: 48 kDa
false
- WB
Unknown
Western blot - Anti-SKP2 antibody (AB68455)
The predicted molecular weight of SKP2 is 48 kDa (SwissProt), however we expect to observe a banding pattern at 53 kDa. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.
All lanes:
Western blot - Anti-SKP2 antibody (ab68455) at 1 µg/mL
Lane 1:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
HEK293 (Human embryonic kidney cell line) Whole Cell Lysate at 10 µg
Lane 3:
Human placenta tissue lysate - total protein (<a href='/en-us/products/unavailable/human-placenta-tissue-lysate-total-protein-ab29745'>ab29745</a>) at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 47 kDa
Observed band size: 29 kDa,38 kDa,53 kDa
true
Exposure time: 1min
- WB
CiteAb
Western blot - Anti-SKP2 antibody (AB68455)
SKP2 western blot using anti-SKP2 antibody ab68455. Publication image and figure legend from Ma, X., Zhao, J., et al., 2017, Oncotarget, PubMed 29137415.
ab68455 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab68455 please see the product overview.
UBE2L3 interacted with SCF (Skp2) complex and promoted p27kip1 ubiquitination and proteasomal degradation(A) Knockdown of UBE2L3 in A549 and NCI-H1299 cells promoted the protein level of p27kip1. (B) Overexpression of UBE2L3 in NCI-H460 and HCC827 cells decreased the protein level of p27kip1. (C) The association between UBE2L3 and SCF (Skp2) complex and p27kip1 was confirmed by immunoprecipitation and immunoblot assay. (D) Overexpression of UBE2L3 promoted the ubiquitination and proteasomal degradation of p27kip1. (E, F) The half-life of p27kip1 was evaluated by CHX assay after UBE2L3 overexpression.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SKP2 is part of the SCF (SKP1-CUL1-F-box) complex which is instrumental in controlling cell cycle and cell division. It regulates the degradation of p27^Kip1 and other cell cycle regulators. By modulating proteolysis SKP2 contributes to the maintenance of cell proliferation and it has essential roles in cellular responses to growth signals. Moreover SKP2 influences processes such as DNA replication through its effect on substrate interaction and ubiquitination.
Pathways
SKP2 functions inside the ubiquitin-proteasome system and impacts the PI3K/AKT signaling pathway. SKP2 advances cell cycle progression by associating with proteins like p27^Kip1 and CDK2 facilitating cell division. It modulates the phosphorylation state of numerous targets influencing signaling processes that control cell growth. This involvement aligns SKP2 with key cellular pathways that maintain cell survival and metabolic balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1304 PubMed40790564
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed36010941
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:695004 PubMed35865382
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 36:e23044 PubMed35499365
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:9214-9227 PubMed34428336
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 206:2366-2375 PubMed33837090
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research 39:190 PubMed32938489
2020
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 14:993-1001 PubMed32184568
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:24 PubMed31911655
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 56:232-242 PubMed31789387
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com